DSCT:TASEIsrael Discount Bank Limited Class A Analysis
Data as of 2026-06-07 - not real-time
ILA 2,987.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock currently trades beneath its short‑term moving averages, signaling continued bearish pressure. Momentum indicators show the RSI in the lower‑mid range, hinting at oversold conditions that could precede a reversal. The MACD line remains below its signal line, reinforcing the prevailing downtrend. Volume has been rising, suggesting that the recent price moves are supported by market participation. Despite the price weakness, the company delivers a high dividend yield that outpaces many peers. The price‑to‑earnings multiple sits comfortably below the sector average, indicating a relative discount.
Fundamental analysis points to a strong cash position and a modest debt profile, enhancing balance‑sheet resilience. The discounted cash‑flow model projects a fair value substantially above the current market level, implying upside potential. Earnings per share are expected to hold steady, supporting the dividend payout sustainability. The bank operates in a regulated environment with stable oversight, limiting abrupt policy shocks. Geographic exposure is concentrated in a single market, which concentrates risk but also benefits from local familiarity. Overall, the combination of valuation headroom, solid dividends, and improving technical signs makes the stock attractive for patient investors.
Fundamental analysis points to a strong cash position and a modest debt profile, enhancing balance‑sheet resilience. The discounted cash‑flow model projects a fair value substantially above the current market level, implying upside potential. Earnings per share are expected to hold steady, supporting the dividend payout sustainability. The bank operates in a regulated environment with stable oversight, limiting abrupt policy shocks. Geographic exposure is concentrated in a single market, which concentrates risk but also benefits from local familiarity. Overall, the combination of valuation headroom, solid dividends, and improving technical signs makes the stock attractive for patient investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish MACD confirming downtrend
- price below short‑term averages
- attractive dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF indicates significant upside
- valuation discount relative to peers
- strong cash generation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- sustainable dividend policy
- stable earnings outlook
- solid balance sheet
Key Metrics & Analysis
Financial Health
Revenue Growth-8.00%
Profit Margin32.00%
P/E Ratio9.4
ROE11.22%
ROA0.86%
P/B Ratio1.1
Op. Cash FlowILA1.7B
Industry P/E17.0
Technical Analysis
TrendBearish
RSI35.1
SupportILA 2,910.00
ResistanceILA 3,310.00
MA 20ILA 3,135.40
MA 50ILA 3,251.68
MA 200ILA 3,398.07
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02
Valuation
Fair ValueILA 4,230.88
Target PriceILA 3,798.75
Upside/Downside27.18%
GradeUndervalued
TypeValue
Dividend Yield5.09%
Risk Assessment
Beta-0.26
Volatility28.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.